Therapy of platinum-resistant cancer

Details Therapy of platinum-resistant cancer Therapy of platinum-resistant cancer

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2567808

The present invention concerns a method for treating platinum-resistant, ovarian cancer, primary peritoneal carcinoma or fallopian tube carcinoma with the combination of a HER2 antibody that effectively inhibits HER dimerization as well as gemcitabine.

L'invention concerne une méthode de traitement du cancer de l'ovaire, du carcinome péritonéal primitif ou du carcinome de la trompe de Fallope résistant au platine, par l'association d'un anticorps HER2 inhibant efficacement la dimérisation de HER, et de gemcitabine.

Affiliated with

Also associated with

Rating

Therapy of platinum-resistant cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapy of platinum-resistant cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapy of platinum-resistant cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1552858